Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study
Author:
Funder
Bayer HealthCare
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference36 articles.
1. Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer;Sullivan;Qual Life Res,2007
2. Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer;Sullivan;Qual Life Res,2006
3. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer;Weinfurt;Ann Oncol,2005
4. Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline;Berruti;J Urol,2000
5. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer—v1.2015; http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Cited by 149 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer;EJNMMI Radiopharmacy and Chemistry;2024-08-24
2. Quantitative single-photon emission computed tomography/computed tomography in assessing the effectiveness of radium-223 dichloride therapy;Cancer Urology;2024-08-15
3. Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies;Cancers;2024-08-06
4. Real‐world safety and effectiveness of radium‐223 in patients with metastatic castration‐resistant prostate cancer: Interim analyses of the prospective, observational RAPIT study;International Journal of Cancer;2024-06-26
5. Next-level precision medicine: why the theragnostic approach is the future;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3